 Tyler Buckner
Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hemophilia A | 28 | 2023 | 70 | 9.390 |
Why?
| | Hemophilia B | 10 | 2023 | 36 | 3.730 |
Why?
| | Quality of Life | 14 | 2023 | 2390 | 1.460 |
Why?
| | Hemarthrosis | 3 | 2023 | 11 | 1.300 |
Why?
| | Pain | 6 | 2022 | 712 | 1.180 |
Why?
| | Anxiety | 6 | 2021 | 855 | 0.960 |
Why?
| | Factor VIII | 6 | 2023 | 54 | 0.940 |
Why?
| | Depression | 6 | 2023 | 1147 | 0.940 |
Why?
| | Pain Management | 3 | 2022 | 291 | 0.930 |
Why?
| | Antibodies, Bispecific | 2 | 2023 | 33 | 0.900 |
Why?
| | Venous Thrombosis | 3 | 2016 | 147 | 0.870 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2022 | 109 | 0.830 |
Why?
| | Patient Reported Outcome Measures | 8 | 2021 | 250 | 0.770 |
Why?
| | Antifibrinolytic Agents | 1 | 2022 | 50 | 0.760 |
Why?
| | Physical Therapists | 1 | 2022 | 38 | 0.760 |
Why?
| | Hemorrhage | 6 | 2023 | 618 | 0.760 |
Why?
| | Venous Thromboembolism | 2 | 2022 | 234 | 0.730 |
Why?
| | Surveys and Questionnaires | 12 | 2023 | 4675 | 0.660 |
Why?
| | Pain Measurement | 2 | 2018 | 449 | 0.650 |
Why?
| | Antibodies | 2 | 2015 | 374 | 0.530 |
Why?
| | United States | 12 | 2023 | 12322 | 0.500 |
Why?
| | Caregivers | 2 | 2018 | 713 | 0.500 |
Why?
| | Factor V Deficiency | 1 | 2014 | 1 | 0.500 |
Why?
| | Hydroxyurea | 1 | 2014 | 30 | 0.490 |
Why?
| | Postoperative Hemorrhage | 3 | 2022 | 78 | 0.490 |
Why?
| | Opioid-Related Disorders | 1 | 2022 | 422 | 0.490 |
Why?
| | Adult | 23 | 2023 | 30822 | 0.450 |
Why?
| | Humans | 41 | 2023 | 115879 | 0.450 |
Why?
| | Severity of Illness Index | 3 | 2018 | 2590 | 0.450 |
Why?
| | Anticoagulants | 2 | 2022 | 549 | 0.450 |
Why?
| | Symptom Assessment | 1 | 2014 | 121 | 0.430 |
Why?
| | Maxillary Sinus | 1 | 2012 | 11 | 0.430 |
Why?
| | Patient Education as Topic | 1 | 2017 | 685 | 0.410 |
Why?
| | Disability Evaluation | 1 | 2014 | 271 | 0.410 |
Why?
| | Thrombophlebitis | 1 | 2012 | 8 | 0.410 |
Why?
| | Pulmonary Embolism | 2 | 2012 | 182 | 0.390 |
Why?
| | Anemia, Sickle Cell | 1 | 2014 | 221 | 0.390 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 2012 | 93 | 0.380 |
Why?
| | Warfarin | 1 | 2012 | 136 | 0.380 |
Why?
| | Survivors | 1 | 2014 | 404 | 0.370 |
Why?
| | Delivery of Health Care | 1 | 2017 | 847 | 0.350 |
Why?
| | Postoperative Complications | 2 | 2022 | 2164 | 0.350 |
Why?
| | Male | 22 | 2023 | 56117 | 0.330 |
Why?
| | Young Adult | 10 | 2023 | 10510 | 0.310 |
Why?
| | Lung Diseases | 1 | 2014 | 710 | 0.310 |
Why?
| | Joint Diseases | 2 | 2018 | 59 | 0.290 |
Why?
| | Autopsy | 1 | 2006 | 86 | 0.270 |
Why?
| | Middle Aged | 13 | 2023 | 27085 | 0.270 |
Why?
| | Population Surveillance | 2 | 2020 | 395 | 0.270 |
Why?
| | Cross-Sectional Studies | 7 | 2023 | 4447 | 0.260 |
Why?
| | Cause of Death | 1 | 2006 | 368 | 0.240 |
Why?
| | Adolescent | 8 | 2021 | 17940 | 0.230 |
Why?
| | Fetomaternal Transfusion | 1 | 2023 | 10 | 0.230 |
Why?
| | Child, Preschool | 5 | 2020 | 9165 | 0.210 |
Why?
| | Aged | 7 | 2021 | 19296 | 0.210 |
Why?
| | Health Services | 1 | 2023 | 104 | 0.200 |
Why?
| | Female | 14 | 2023 | 60082 | 0.190 |
Why?
| | Graft vs Host Disease | 1 | 2023 | 210 | 0.190 |
Why?
| | Hemostatics | 1 | 2021 | 48 | 0.190 |
Why?
| | Premedication | 1 | 2020 | 36 | 0.180 |
Why?
| | Practice Patterns, Physicians' | 2 | 2022 | 1182 | 0.180 |
Why?
| | Neoplasms | 1 | 2014 | 2115 | 0.180 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1405 | 0.180 |
Why?
| | Research | 1 | 2023 | 398 | 0.170 |
Why?
| | Cost of Illness | 1 | 2021 | 257 | 0.160 |
Why?
| | Physical Therapy Modalities | 1 | 2022 | 269 | 0.160 |
Why?
| | Pregnancy Complications | 1 | 2023 | 431 | 0.160 |
Why?
| | Blood Coagulation Disorders | 1 | 2021 | 196 | 0.160 |
Why?
| | Activities of Daily Living | 2 | 2018 | 352 | 0.160 |
Why?
| | Prospective Studies | 2 | 2022 | 6279 | 0.150 |
Why?
| | Musculoskeletal Pain | 1 | 2017 | 23 | 0.150 |
Why?
| | Health Care Costs | 1 | 2021 | 384 | 0.150 |
Why?
| | Child | 5 | 2020 | 18539 | 0.150 |
Why?
| | Comorbidity | 2 | 2018 | 1476 | 0.140 |
Why?
| | Prevalence | 2 | 2020 | 2270 | 0.140 |
Why?
| | Blood Coagulation Factor Inhibitors | 1 | 2015 | 2 | 0.130 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2020 | 666 | 0.130 |
Why?
| | Patient Acceptance of Health Care | 1 | 2021 | 682 | 0.130 |
Why?
| | Risk Factors | 3 | 2020 | 8715 | 0.120 |
Why?
| | Analgesics, Opioid | 1 | 2022 | 783 | 0.120 |
Why?
| | Publications | 1 | 2014 | 37 | 0.120 |
Why?
| | Infant | 3 | 2020 | 7992 | 0.120 |
Why?
| | Infant, Newborn | 2 | 2020 | 5084 | 0.120 |
Why?
| | Quality Improvement | 1 | 2021 | 958 | 0.110 |
Why?
| | Self Report | 1 | 2017 | 700 | 0.110 |
Why?
| | Remission, Spontaneous | 1 | 2012 | 37 | 0.110 |
Why?
| | Enterocolitis, Pseudomembranous | 1 | 2012 | 25 | 0.110 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2016 | 246 | 0.100 |
Why?
| | Hospitalization | 1 | 2021 | 1766 | 0.100 |
Why?
| | Sickle Cell Trait | 1 | 2012 | 14 | 0.100 |
Why?
| | Odds Ratio | 2 | 2015 | 968 | 0.100 |
Why?
| | Case Management | 1 | 2012 | 62 | 0.100 |
Why?
| | Sex Factors | 1 | 2017 | 1741 | 0.100 |
Why?
| | Thrombophilia | 1 | 2012 | 67 | 0.100 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 82 | 0.100 |
Why?
| | Genetic Therapy | 2 | 2023 | 267 | 0.090 |
Why?
| | North Carolina | 1 | 2010 | 98 | 0.090 |
Why?
| | Ultrasonography, Doppler | 1 | 2010 | 105 | 0.090 |
Why?
| | Risk | 1 | 2012 | 829 | 0.080 |
Why?
| | Ultrasonography | 1 | 2012 | 669 | 0.080 |
Why?
| | Cohort Studies | 1 | 2016 | 4960 | 0.070 |
Why?
| | Incidental Findings | 1 | 2006 | 77 | 0.070 |
Why?
| | Diagnostic Errors | 1 | 2006 | 151 | 0.060 |
Why?
| | Retrospective Studies | 1 | 2022 | 12616 | 0.060 |
Why?
| | Logistic Models | 1 | 2010 | 1863 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 2020 | 1244 | 0.060 |
Why?
| | Medical Oncology | 1 | 2006 | 230 | 0.060 |
Why?
| | Reproducibility of Results | 2 | 2021 | 2807 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 1 | 2012 | 2201 | 0.060 |
Why?
| | Risk Assessment | 1 | 2010 | 2992 | 0.050 |
Why?
| | Half-Life | 1 | 2021 | 145 | 0.050 |
Why?
| | Plasmapheresis | 1 | 2020 | 22 | 0.050 |
Why?
| | Factor VIIa | 1 | 2020 | 36 | 0.040 |
Why?
| | Choice Behavior | 1 | 2021 | 159 | 0.040 |
Why?
| | Obesity | 1 | 2012 | 2523 | 0.040 |
Why?
| | Rituximab | 1 | 2020 | 149 | 0.040 |
Why?
| | Patient Preference | 1 | 2021 | 171 | 0.040 |
Why?
| | Time-to-Treatment | 1 | 2020 | 147 | 0.040 |
Why?
| | Fetus | 1 | 2023 | 703 | 0.040 |
Why?
| | Primary Prevention | 1 | 2020 | 170 | 0.040 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2023 | 524 | 0.040 |
Why?
| | Medication Adherence | 1 | 2023 | 538 | 0.040 |
Why?
| | Swine | 1 | 2020 | 705 | 0.040 |
Why?
| | Psychometrics | 1 | 2020 | 615 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2020 | 510 | 0.030 |
Why?
| | Patient-Centered Care | 1 | 2021 | 477 | 0.030 |
Why?
| | Time Factors | 1 | 2006 | 6182 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 728 | 0.030 |
Why?
| | Perception | 1 | 2018 | 316 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2023 | 976 | 0.030 |
Why?
| | Demography | 1 | 2015 | 264 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2015 | 466 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3344 | 0.030 |
Why?
| | Pregnancy | 1 | 2023 | 5555 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 6434 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 9164 | 0.020 |
Why?
| | Animals | 1 | 2020 | 32162 | 0.010 |
Why?
|
|
Buckner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|